Frank N. van Leeuwen

University of Copenhagen — Denmark

Medicine · Health Sciences

51h-index9.9kcitations199works2.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Lymphoblastic Leukemia research(65), Cancer-related gene regulation(29), Magnesium in Health and Disease(20), Chronic Myeloid Leukemia Treatments(19), Acute Myeloid Leukemia Research(15)

Publications199 total

Modern radiotherapy for Hodgkin lymphoma – associated radiation doses and predicted second cancer risks
Klinische Pädiatrie·2025
A non-canonical lymphoblast in refractory childhood T-cell leukaemia
Nature Communications·2025Open Access
Underlying biology, challenges and emergent concepts in the treatment of relapsed and refractory pediatric T-cell acute lymphoblastic leukemia
Leukemia·2025Open Access
Treatment-related mutagenic processes in acute lymphoblastic leukemia
Haematologica·2025Open Access
S-adenosylmethionine addiction confers sensitivity to methionine restriction in <i>KMT2A</i>-rearranged acute lymphoblastic leukemia
Haematologica·2025· 1 citedOpen Access
CpG island methylator phenotype classification improves risk assessment in pediatric T-cell acute lymphoblastic leukemia
Blood·2025· 8 citedOpen Access
Loss of p53 impairs death receptor expression and confers resistance to CD19 CAR T-cell therapy in BCP-ALL
Blood Neoplasia·2024· 5 citedOpen Access
A Non-Canonical Lymphoblast in Refractory Childhood T-Cell Acute Lymphoblastic Leukemia
Blood·2024· 2 cited
Abstract A025 Single cell transcriptomics reveals a non-canonical lymphoblast in refractory childhood T cell leukaemia
Cancer Research·2024
Mutational mechanisms in multiply relapsed pediatric acute lymphoblastic leukemia
Leukemia·2024· 12 citedOpen Access
<i>IKZF1</i> in acute lymphoblastic leukemia: the rise before the fall?
Leukemia & lymphoma/Leukemia and lymphoma·2024· 7 cited
&lt;i&gt;IKZF1&lt;/i&gt; gene deletions drive resistance to cytarabine in B-cell precursor acute lymphoblastic leukemia
Haematologica·2024· 3 citedOpen Access
The role of the mineralocorticoid receptor in steroid-induced cytotoxicity in pediatric acute lymphoblastic leukemia
Haematologica·2024Open Access
Histone deacetylase inhibition sensitizes p53-deficient B-cell precursor acute lymphoblastic leukemia to chemotherapy
Haematologica·2023· 4 citedOpen Access
Loss of p53 Impairs Death Receptor Expression and Confers Resistance to CD19-Directed CAR T-Cell Therapy in B-Cell Precursor Acute Lymphoblastic Leukemia
Blood·2023· 1 citedOpen Access
TP53 Aberrant B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) Are Uniquely Sensitive to a Combination of Pyrimidine De Novo Synthesis Blockade and Replication Checkpoint Inhibition
Blood·2023Open Access
Predicting target lesion failure following percutaneous coronary intervention through machine learning risk assessment models
European Heart Journal - Digital Health·2023· 5 citedOpen Access
The Prognostic Effect of IKZF1 Deletions in ETV6::RUNX1 and High Hyperdiploid Childhood Acute Lymphoblastic Leukemia
HemaSphere·2023· 14 citedOpen Access
Btg1 and Btg2 regulate neonatal cardiomyocyte cell cycle arrest
Journal of Molecular and Cellular Cardiology·2023· 10 citedOpen Access
Supplementary Table 3 from A First Step toward Personalized Medicine in Osteosarcoma: Pharmacogenetics as Predictive Marker of Outcome after Chemotherapy-Based Treatment
2023Open Access
page 1 of 10Next →

Frequent Co-authors

Carl G. Figdor(12), Blanca Scheijen(10), Roland P. Kuiper(10), Peter M. Hoogerbrugge(9), Kristopher Clark(8), Jeroen Middelbeek(8), Esmé Waanders(7), Ad Geurts van Kessel(6), Laurens T. van der Meer(5), John G. Collard(5), Kees Jalink(5), Edwin Sonneveld(5), Rob A. van der Kammen(4), Michiel Langeslag(4), Wouter H. Moolenaar(4), Simon V. van Reijmersdal(4), Ben Joosten(4), Suzanne F. G. van Helden(4), Liesbeth van Emst(4), Hendrie E.T. Kain(3)